Hence, the 44 natural phytochemicals emphasized as BDNF inducers were selected for the study to assess their multitargeting potential against the target proteins AChE, BuChE, GSK3β, MOA-A, MOA-B, and NDMA as a potential molecule for treating AD. This evidence concerns the gene GSK3B and Alzheimer disease.